Alnylam Pharma (ALNY) Tops Q1 EPS by 35c
Tweet
Share
E-mail
Get Alerts ALNY Hot Sheet
Price: $239.55 +4.79%
Financial Fact:
Net revenues from research collaborators: 8.71M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Financial Fact:
Net revenues from research collaborators: 8.71M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q1 EPS of ($1.49), $0.35 better than the analyst estimate of ($1.84). Revenue for the quarter came in at $213.26 million versus the consensus estimate of $243.02 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Starts Alnylam Pharmaceuticals (ALNY) at Outperform
- Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
- ZIM Integrated Shipping Services Ltd. (ZIM) Tops Q2 EPS by 82c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
